Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.812
+0.022 (1.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.790
-0.022 (-1.23%)
After-hours: Jun 26, 2026, 4:00 PM EDT
Innate Pharma Employees
Innate Pharma had 164 employees as of December 31, 2025. The number of employees decreased by 17 or -9.39% compared to the previous year.
Employees
164
Change (1Y)
-17
Growth (1Y)
-9.39%
Revenue / Employee
$64,469
Profits / Employee
-$352,072
Market Cap
168.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| LENZ Therapeutics | 152 |
| Precision BioSciences | 66 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 49 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
IPHA News
- 5 weeks ago - Outcome of Innate Pharma's 2026 Annual General Meeting - Business Wire
- 5 weeks ago - Innate Pharma to participate in the Jefferies Global Healthcare Conference - Business Wire
- 6 weeks ago - Innate Pharma Q1 Earnings Call Highlights - MarketBeat
- 6 weeks ago - Innate Pharma Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Innate Pharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Slides: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Earnings release: Q1 2026 - Filings
- 6 weeks ago - Innate Pharma Slides: Corporate presentation - Filings